The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for ...
The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback